Detalhe da pesquisa
1.
Highly Attenuated Poxvirus-Based Vaccines Against Emerging Viral Diseases.
J Mol Biol
; 435(15): 168173, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37301278
2.
Lung transcriptomics of K18-hACE2 mice highlights mechanisms and genes involved in the MVA-S vaccine-mediated immune response and protection against SARS-CoV-2 infection.
Antiviral Res
; 220: 105760, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37992765
3.
Optimized vaccine candidate MVA-S(3P) fully protects against SARS-CoV-2 infection in hamsters.
Front Immunol
; 14: 1163159, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37920464
4.
Preclinical immune efficacy against SARS-CoV-2 beta B.1.351 variant by MVA-based vaccine candidates.
Front Immunol
; 14: 1264323, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38155964
5.
Full protection from SARS-CoV-2 brain infection and damage in susceptible transgenic mice conferred by MVA-CoV2-S vaccine candidate.
Nat Neurosci
; 26(2): 226-238, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36624276
6.
Dendritic Cell-Mediated Cross-Priming by a Bispecific Neutralizing Antibody Boosts Cytotoxic T Cell Responses and Protects Mice against SARS-CoV-2.
Adv Sci (Weinh)
; 10(34): e2304818, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37863812
7.
MVA-CoV2-S Vaccine Candidate Neutralizes Distinct Variants of Concern and Protects Against SARS-CoV-2 Infection in Hamsters.
Front Immunol
; 13: 845969, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35371064
8.
Intranasal administration of a single dose of MVA-based vaccine candidates against COVID-19 induced local and systemic immune responses and protects mice from a lethal SARS-CoV-2 infection.
Front Immunol
; 13: 995235, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36172368
9.
A Single Dose of an MVA Vaccine Expressing a Prefusion-Stabilized SARS-CoV-2 Spike Protein Neutralizes Variants of Concern and Protects Mice From a Lethal SARS-CoV-2 Infection.
Front Immunol
; 12: 824728, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-35154086